• Home
  • BLOG
  • THÈMES
    • VIH/SIDA
    • Tuberculose
    • Paludisme
    • Oncologie et soins palliatifs
    • Maladies non transmissibles
    • Maladies tropicales négligées
    • Santé maternelle et reproductive
    • Hépatites
    • Contrôle des épidémies
  • Produits
    • Médicaments essentiels
    • Fournitures médicales
    • Fournitures chirurgicales
    • Kits
    • Premiers secours
  • Services
    • Vente en gros
    • Chaine logistique
    • Services d’approvisionnement
    • NCDconnect
    • Services locaux
  • Qualité
  • Qui nous sommes
    • Notre équipe dirigeante
    • Nos équipes
    • Nos objectifs
    • Éthique
    • Nous agissons
    • Postes à pourvoir
    • Nos bureaux et page de contact
  • Viabilité écologique
  • Log In
  • English English
  • Home
  • BLOG
  • THÈMES
    • VIH/SIDA
    • Tuberculose
    • Paludisme
    • Oncologie et soins palliatifs
    • Maladies non transmissibles
    • Maladies tropicales négligées
    • Santé maternelle et reproductive
    • Hépatites
    • Contrôle des épidémies
  • Produits
    • Médicaments essentiels
    • Fournitures médicales
    • Fournitures chirurgicales
    • Kits
    • Premiers secours
  • Services
    • Vente en gros
    • Chaine logistique
    • Services d’approvisionnement
    • NCDconnect
    • Services locaux
  • Qualité
  • Qui nous sommes
    • Notre équipe dirigeante
    • Nos équipes
    • Nos objectifs
    • Éthique
    • Nous agissons
    • Postes à pourvoir
    • Nos bureaux et page de contact
  • Viabilité écologique
  • Log In
  • English English
Invitation to bid (ITB) on behalf of Stop TB/GDF

Invitation to bid (ITB) on behalf of Stop TB/GDF

par Stephan Lust | Fév 24, 2023 | Global Drug Facility, Stop TB Partnership

24 February 2023, Geneva, Switzerland – On behalf of Stop TB Partnership’s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF- contracted procurement agent, invites all eligible suppliers to submit bids (ITB) for: ITB-IDA/GDF-MED/2023/1, pretomanid...
Invitation to bid (ITB) on behalf of Stop TB/GDF

Invitation to bid (ITB) on behalf of Stop TB/GDF

par Stephan Lust | Avr 11, 2022 | Global Drug Facility, Stop TB Partnership

UPDATE 26 April 2022 – Reminder Please be informed that for the ITB-IDA/GDF – MED/2022/1, the deadline for submission/modification of product/s in FPP In-Market and/or country registration in FPP registration modules, including uploading of...
Investing to end TB

Investing to end TB

par Stephan Lust | Mar 24, 2022 | Global Drug Facility, IDA Team, Stop TB Partnership

Amsterdam, 24 March 2022 – Tuberculosis (TB) is one of the world’s most common and life threatening diseases, with over 95% of TB deaths occurring in low-and middle-income countries (LMICs). In 2019, an estimated 10 million people were diagnosed with TB worldwide...
Invitation to bid (ITB) on behalf of Stop TB/GDF

Invitation to bid (ITB) on behalf of Stop TB/GDF

par Stephan Lust | Mai 17, 2021 | Global Drug Facility, Stop TB Partnership

17 May 2021 – Geneva, Switzerland – On behalf of Stop TB Partnership’s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF- contracted procurement agent, invites all eligible suppliers to submit bids (ITB) for: ITB-IDA/GDF-FLD/2021/001, for...
Invitation to Bid (ITB) on behalf of Stop TB/GDF

Invitation to Bid (ITB) on behalf of Stop TB/GDF

par Stephan Lust | Sep 23, 2020 | Global Drug Facility, News, Stop TB Partnership

22 September 2020 – Geneva, Switzerland – On behalf of Stop TB Partnership’s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF- contracted procurement agent, invites all eligible suppliers to submit bids (ITB) for: ITB-IDA/GDF-FLD/2020/001,...
Price reduction of bedaquiline in the fight against TB

Price reduction of bedaquiline in the fight against TB

par Stephan Lust | Juil 7, 2020 | Global Drug Facility, Global Fund, Johnson & Johnson, News, Stop TB Partnership, USAID

On Monday July 6, Johnson & Johnson announced a price reduction of the anti-tuberculosis medicine bedaquiline, for low- and middle-income countries. Thanks to the support of USAID and the Global Fund, this price reduction could be achieved. The price dropped...
« Entrées précédentes

Recent Posts

  • Double Materiality at IDA Foundation: Refining Our Sustainability Priorities for 2030
  • Safeguarding Oncology Treatment: The Importance of Medicine Quality in LMICs
  • Ecovadis Silver medal for IDA Foundation
  • NCDconnect: IDA Foundation’s solution to NCD Challenges
  • IDA’s Sustainability Journey – Working with our logistics partners on alternative fuel options in our supply chains

Recent Comments

Aucun commentaire à afficher.

Clients
Agents et Distributeurs
Fournisseurs

Copyright IDA Foundation ©




Conditions générales de ventes
FAQ
Déclaration de confidentialité
Conditions d'utilisation du site

Contact

P.O. Box 37098
1030 AB Amsterdam
The Netherlands
+31 (0)20 403 3051
info@idafoundation.org